Valuation: MedPacto, Inc.

Market Cap 119B 81.98M 71.94M 67M 61.62M 116M 7.83B 117M 795M 311M 3.88B 308M 301M 13.42B P/E 2024
-7.42x
P/E 2025 -17.9x
Enterprise Value 80.3B 55.19M 48.44M 45.1M 41.49M 77.77M 5.27B 79.1M 535M 209M 2.61B 207M 203M 9.03B EV / Sales 2024
-
EV / Sales 2025 48,733,025x
Free-Float
74%
Yield 2024 *
-
Yield 2025 -
1 day+29.85%
1 week+32.57%
Current month+10.65%
1 month+23.84%
3 months-36.61%
6 months-48.75%
Current year-47.90%
1 week 2,555
Extreme 2555
3,480
1 month 2,545
Extreme 2545
3,480
Current year 2,545
Extreme 2545
7,980
1 year 2,545
Extreme 2545
8,650
3 years 2,545
Extreme 2545
17,240
5 years 2,545
Extreme 2545
69,600
10 years 2,545
Extreme 2545
134,200
Manager TitleAgeSince
Chief Executive Officer 72 2013-06-18
President 66 2024-03-27
Corporate Officer/Principal 67 -
Director TitleAgeSince
Director/Board Member 72 2013-06-18
Director/Board Member 63 2024-03-27
Director/Board Member 74 2024-03-27
Date Insider Type Main position Quantity % Market Cap.
3/4/25 Buy

Chairperson

15,000 0.0438%
3/4/25 Buy 10,000 0.0292%
3/4/25 Buy

Chairperson

15,000 0.0438%
Change 5-day change 1-year change 3-year change Capi.($)
+29.85%+32.57%-16.95%-76.12% 62.56M
-2.25%+1.55%+50.84%+70.04% 56.19B
-1.32%-2.71%+34.27%+77.57% 54.83B
+1.49%+0.13%-18.03%-13.94% 23.04B
-0.57%-4.13%+2.34%+387.73% 22.7B
+1.45%+0.98%+16.73%-11.07% 20.23B
0.00%+3.00%+27.41%-29.52% 17.83B
-3.24%-5.42%+24.05%+547.25% 15.65B
-6.69%-5.11%+169.13%+304.89% 15.24B
+1.25%+0.69%+27.30%+184.69% 14.03B
Average +1.96%+3.36%+31.71%+144.15% 23.98B
Weighted average by Cap. -1.19%-0.21%+35.60%+132.26%

Financials

2024 2025
Net sales - 3.9K 2.68 2.35 2.19 2.01 3.78 255.98 3.84 25.98 10.17 126.95 10.06 9.84 438.61
Net income -20.14B -13.84M -12.15M -11.31M -10.4M -19.5M -1.32B -19.84M -134M -52.53M -656M -51.97M -50.84M -2.27B -12.81B -8.8M -7.73M -7.2M -6.62M -12.41M -841M -12.62M -85.37M -33.41M -417M -33.05M -32.34M -1.44B
Net Debt -53.54B -36.8M -32.29M -30.07M -27.66M -51.85M -3.52B -52.74M -357M -140M -1.74B -138M -135M -6.02B -38.97B -26.79M -23.51M -21.89M -20.13M -37.74M -2.56B -38.39M -260M -102M -1.27B -101M -98.39M -4.38B
Logo MedPacto, Inc.
MedPacto, Inc. is a Korea-based company principally engaged in the research and development of biopharmaceuticals. The Company researches and develops anticancer drugs and diagnostic kits including vactosertib, MA-B2 and others. The products are used as the treatment of multiple myeloma, lung cancer, stomach cancer, colon cancer, blood cancer, triple negative breast cancer and pancreatic cancer, among others.
Employees
-
Date Price Change Volume
26-07-28 ₩3,480.00 +29.85% 564,293
26-07-27 ₩2,680.00 -1.29% 101,560
26-07-24 ₩2,715.00 -0.18% 125,443
26-07-23 ₩2,720.00 +5.63% 99,651
26-07-22 ₩2,575.00 -1.90% 96,274
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC

Net sales - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A235980 Stock